Bris­tol My­ers inks pro­tein de­grad­er deal via Cel­gene team's link to seed-stage biotech

Bris­tol My­ers Squibb is adding to its pro­tein de­grad­er line­up, which al­ready in­cludes the likes of A-Al­pha Bio and Evotec, by link­ing arms with a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.